首页 > 最新文献

Austin journal of analytical and pharmaceutical chemistry最新文献

英文 中文
Association of Polyphenol Oxidase Activities with Molecular Markers and Yellow Rust Resistance in Diverse Bread Wheat Genotypes 不同面包小麦基因型多酚氧化酶活性与分子标记及抗黄锈性的关系
Pub Date : 2021-09-03 DOI: 10.26420/austinjanalpharmchem.2021.1134
Asghar Mn, Bajwa Aa, A. A., M. A, S. A., S. Sm
Polyphenol Oxidase (PPO) catalyses the undesirable browning of wheat products which is of significant concern in consumer acceptance perspectives. Another important yield-limiting cause for wheat crops is wheat rust (e.g., yellow rust), a source of great economic loss worldwide. The purpose of the current research was to screen conventional and synthetic bread wheat genotypes for their PPO activity and yellow rust resistance. Different genotypes differed significantly in total PPO activity and in their activities against different substrates (L-DOPA and Catechol). The synthetically derived bread wheat genotypes 1-279, showed the lowest (39.2 units/min/g) cumulative PPO activity. Ten genotypes each with the highest and lowest PPO activities were selected for testing their association with seven reported molecular markers. Intriguingly the PPO markers reported in literature could not clearly differentiate between contrasting cultivars. Association with yellow rust resistance was also investigated. Interestingly, the rust-resistant genotypes, including 1-263, Ch-43, 1-57 and Emat (all synthetic-derived), exhibited low PPO activity. The current study underpins that there is a need to search for more reliable PPO markers and to further validate association of low PPO activity with yellow rust.
多酚氧化酶(PPO)催化小麦产品的不良褐变,这是在消费者接受的观点显著关注。小麦作物产量受限的另一个重要原因是小麦锈病(如黄锈病),这是全世界重大经济损失的来源。本研究的目的是筛选常规和合成面包小麦基因型的PPO活性和抗黄锈性。不同基因型的总PPO活性及其对不同底物(左旋多巴和儿茶酚)的活性差异显著。合成衍生的面包小麦基因型1-279的累积PPO活性最低,为39.2单位/min/g。选择PPO活性最高和最低的10个基因型,检测它们与7个已报道的分子标记的相关性。有趣的是,文献报道的PPO标记不能明显区分不同品种。并对其与抗黄锈性的关系进行了研究。有趣的是,抗锈病基因型,包括1-263、Ch-43、1-57和Emat(都是合成衍生的),显示出较低的PPO活性。目前的研究表明,有必要寻找更可靠的PPO标记,并进一步验证低PPO活性与黄锈病的关联。
{"title":"Association of Polyphenol Oxidase Activities with Molecular Markers and Yellow Rust Resistance in Diverse Bread Wheat Genotypes","authors":"Asghar Mn, Bajwa Aa, A. A., M. A, S. A., S. Sm","doi":"10.26420/austinjanalpharmchem.2021.1134","DOIUrl":"https://doi.org/10.26420/austinjanalpharmchem.2021.1134","url":null,"abstract":"Polyphenol Oxidase (PPO) catalyses the undesirable browning of wheat products which is of significant concern in consumer acceptance perspectives. Another important yield-limiting cause for wheat crops is wheat rust (e.g., yellow rust), a source of great economic loss worldwide. The purpose of the current research was to screen conventional and synthetic bread wheat genotypes for their PPO activity and yellow rust resistance. Different genotypes differed significantly in total PPO activity and in their activities against different substrates (L-DOPA and Catechol). The synthetically derived bread wheat genotypes 1-279, showed the lowest (39.2 units/min/g) cumulative PPO activity. Ten genotypes each with the highest and lowest PPO activities were selected for testing their association with seven reported molecular markers. Intriguingly the PPO markers reported in literature could not clearly differentiate between contrasting cultivars. Association with yellow rust resistance was also investigated. Interestingly, the rust-resistant genotypes, including 1-263, Ch-43, 1-57 and Emat (all synthetic-derived), exhibited low PPO activity. The current study underpins that there is a need to search for more reliable PPO markers and to further validate association of low PPO activity with yellow rust.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42776708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Chicken Spleen Transfer Factor on Intestinal Mucosa Immunity Barrier of Laying Hens 鸡脾转移因子对蛋鸡肠黏膜免疫屏障的影响
Pub Date : 2021-08-07 DOI: 10.26420/austinjanalpharmchem.2021.1133
Yu J, M. B, L. J., Chen Y, W. Z, C. J, D. Y
Chicken spleen Transfer Factor (TF) is a low-molecular-weight lymphocyte extract composed of polypeptide and nucleotide. However, its role in regulating intestinal structure and function in laying hens has remained largely unknown. 100 one-day-old laying hens were randomly divided into five groups and administered with different doses of TF (0.00 [control], 0.05mL, 0.10mL, 0.25mL and 1.00mL). The results showed that the high dose of TF (1.00mL) improved the intestinal mucosa morphology and strengthened the digestive and absorption function. Furthermore, the histology analysis revealed an increase in the number of intraepithelial lymphocytes and goblet cells. Similarly, the results from ELISA demonstrated an increase in the content of IL-10 in the intestinal tract, while the content of TNF-a showed a decrease in this regard. The RT-PCR assay also demonstrated the upregulation of the relative mRNA expressions of Muc2, TLR-2, and TLR-4 genes. The intestinal antioxidant function was significantly enhanced. In conclusion, high-dose of TF can improve the intestinal mucosa morphology and structure, enhance digestion and absorption functions, enhance the intestinal mucosal barrier immune function and antioxidant function, and up-regulate Muc2, TLR-2 and TLR-4 gene relative expression.
鸡脾转移因子(TF)是一种由多肽和核苷酸组成的低分子淋巴细胞提取物。然而,其在调节蛋鸡肠道结构和功能中的作用仍不清楚。选取100只1日龄蛋鸡,随机分为5组,分别饲喂不同剂量的TF(0.00[对照]、0.05mL、0.10mL、0.25mL和1.00mL)。结果表明,高剂量(1.00mL) TF可改善大鼠肠黏膜形态,增强消化吸收功能。此外,组织学分析显示上皮内淋巴细胞和杯状细胞数量增加。同样,ELISA结果显示肠道中IL-10含量增加,而TNF-a含量减少。RT-PCR检测也显示Muc2、TLR-2和TLR-4基因的相对mRNA表达上调。肠道抗氧化功能显著增强。由此可见,高剂量TF可改善肠黏膜形态结构,增强消化吸收功能,增强肠黏膜屏障免疫功能和抗氧化功能,上调Muc2、TLR-2和TLR-4基因的相对表达。
{"title":"The Effect of Chicken Spleen Transfer Factor on Intestinal Mucosa Immunity Barrier of Laying Hens","authors":"Yu J, M. B, L. J., Chen Y, W. Z, C. J, D. Y","doi":"10.26420/austinjanalpharmchem.2021.1133","DOIUrl":"https://doi.org/10.26420/austinjanalpharmchem.2021.1133","url":null,"abstract":"Chicken spleen Transfer Factor (TF) is a low-molecular-weight lymphocyte extract composed of polypeptide and nucleotide. However, its role in regulating intestinal structure and function in laying hens has remained largely unknown. 100 one-day-old laying hens were randomly divided into five groups and administered with different doses of TF (0.00 [control], 0.05mL, 0.10mL, 0.25mL and 1.00mL). The results showed that the high dose of TF (1.00mL) improved the intestinal mucosa morphology and strengthened the digestive and absorption function. Furthermore, the histology analysis revealed an increase in the number of intraepithelial lymphocytes and goblet cells. Similarly, the results from ELISA demonstrated an increase in the content of IL-10 in the intestinal tract, while the content of TNF-a showed a decrease in this regard. The RT-PCR assay also demonstrated the upregulation of the relative mRNA expressions of Muc2, TLR-2, and TLR-4 genes. The intestinal antioxidant function was significantly enhanced. In conclusion, high-dose of TF can improve the intestinal mucosa morphology and structure, enhance digestion and absorption functions, enhance the intestinal mucosal barrier immune function and antioxidant function, and up-regulate Muc2, TLR-2 and TLR-4 gene relative expression.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43641845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the Inhibition Effect of Portulaca oleracea against SARS-CoV-2 through Molecular Docking Simulation 马齿苋对SARS-CoV-2抑制作用的分子对接模拟研究
Pub Date : 2021-05-05 DOI: 10.26420/AUSTINJANALPHARMCHEM.2021.1132
Elizariev An, Zaki Eg, el-Kousy Sm
Recently a new virus strain designated as SARS coronavirus result in a fatal pandemic known as COVID-19. Bioinformatics and drug screening are directed for the assessment of potential inhibitors before their clinical implementation for the treatment of this fatal pneumonia. One of the expected natural potent inhibitors is Portulaca oleracea which has been assigned as an effective drug to different human ailments throughout the whole world. P. oleracea is widely spread in most areas of Egypt. In the current study, hydrophilic polysaccharides were purified from Portulaca oleracea extracts. Molecular docking simulation is implemented to investigate the antiviral effect of the purified polysaccharides to inhibit COVID-19. The viral protease was downloaded from a Protein Data Bank (PDB# 6y84) then docked with the potent inhibitors. The docking results indicate that the purified polysaccharides can bind tightly to the SARS-CoV-2 viral protease, which indicates that P. oleracea is a potential inhibitor for COVID-19.
最近,一种被命名为SARS冠状病毒的新病毒株导致了一种名为COVID-19的致命大流行。生物信息学和药物筛选的目的是在临床实施治疗这种致命肺炎之前评估潜在的抑制剂。马齿苋是一种预期的天然有效抑制剂,它已被指定为一种有效的药物,治疗全世界不同的人类疾病。马舌兰在埃及的大部分地区广泛分布。本研究从马齿苋提取物中纯化亲水性多糖。通过分子对接模拟研究纯化多糖对COVID-19的抗病毒作用。从蛋白质数据库(PDB# 6y84)下载病毒蛋白酶,然后与有效抑制剂对接。对接结果表明,纯化后的多糖可与SARS-CoV-2病毒蛋白酶紧密结合,表明马马苋是一种潜在的COVID-19抑制剂。
{"title":"Investigating the Inhibition Effect of Portulaca oleracea against SARS-CoV-2 through Molecular Docking Simulation","authors":"Elizariev An, Zaki Eg, el-Kousy Sm","doi":"10.26420/AUSTINJANALPHARMCHEM.2021.1132","DOIUrl":"https://doi.org/10.26420/AUSTINJANALPHARMCHEM.2021.1132","url":null,"abstract":"Recently a new virus strain designated as SARS coronavirus result in a fatal pandemic known as COVID-19. Bioinformatics and drug screening are directed for the assessment of potential inhibitors before their clinical implementation for the treatment of this fatal pneumonia. One of the expected natural potent inhibitors is Portulaca oleracea which has been assigned as an effective drug to different human ailments throughout the whole world. P. oleracea is widely spread in most areas of Egypt. In the current study, hydrophilic polysaccharides were purified from Portulaca oleracea extracts. Molecular docking simulation is implemented to investigate the antiviral effect of the purified polysaccharides to inhibit COVID-19. The viral protease was downloaded from a Protein Data Bank (PDB# 6y84) then docked with the potent inhibitors. The docking results indicate that the purified polysaccharides can bind tightly to the SARS-CoV-2 viral protease, which indicates that P. oleracea is a potential inhibitor for COVID-19.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42414193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of TLC-Spectrodensitometric and Chemometric Methods for Determination of Momenta® Cream: A Comparative Study Applied on Ternary Mixture 薄层色谱法和化学法测定Momenta®乳膏的应用——三元混合物的对比研究
Pub Date : 2021-03-10 DOI: 10.26420/AUSTINJANALPHARMCHEM.2021.1131
H. Salem, Omar Ma, Derayea Sm, Khalil Aa
A comparative study for the validation and advancement of two analytical approaches applied for the simultaneous determination of Mometasone Furoate (MF), Miconazole Nitrate (MIC) and Gentamicin (GM) formulated in Momenta® cream. The first approach was TLC-spectrodensitometric method, which was advanced by separating the three components on TLC aluminum plates coated with silica gel 60 F254 using chloroform: methanol: formic acid (4:0.3:0.15, v/v/v) as a mobile phase, then scanned at 254nm using Camage TLC scanner 3 operated in reflectance-absorbance mode. The second approach was the chemometric method using two models: Partial Least Squares (PLS) and Principle Component Regression Model (PCR). The proposed approaches were validated according to ICH guidelines and were applied for the determination of the ternary mixtures in their analytical mixtures and pharmaceutical preparation.
一项用于同时测定Momenta®乳膏中配制的糠酸莫米松(MF)、硝酸咪康唑(MIC)和庆大霉素(GM)的两种分析方法的验证和改进的比较研究。第一种方法是TLC光谱密度测定法,该方法是通过使用氯仿:甲醇:甲酸(4:0.3:0.15,v/v/v)作为流动相,在涂有硅胶60F254的TLC铝板上分离三种成分,然后使用Camage TLC扫描仪3在254nm下扫描,该扫描仪在反射-吸收模式下操作。第二种方法是使用两个模型的化学计量方法:偏最小二乘(PLS)和主成分回归模型(PCR)。根据ICH指南验证了所提出的方法,并将其应用于分析混合物和药物制剂中三元混合物的测定。
{"title":"Application of TLC-Spectrodensitometric and Chemometric Methods for Determination of Momenta® Cream: A Comparative Study Applied on Ternary Mixture","authors":"H. Salem, Omar Ma, Derayea Sm, Khalil Aa","doi":"10.26420/AUSTINJANALPHARMCHEM.2021.1131","DOIUrl":"https://doi.org/10.26420/AUSTINJANALPHARMCHEM.2021.1131","url":null,"abstract":"A comparative study for the validation and advancement of two analytical approaches applied for the simultaneous determination of Mometasone Furoate (MF), Miconazole Nitrate (MIC) and Gentamicin (GM) formulated in Momenta® cream. The first approach was TLC-spectrodensitometric method, which was advanced by separating the three components on TLC aluminum plates coated with silica gel 60 F254 using chloroform: methanol: formic acid (4:0.3:0.15, v/v/v) as a mobile phase, then scanned at 254nm using Camage TLC scanner 3 operated in reflectance-absorbance mode. The second approach was the chemometric method using two models: Partial Least Squares (PLS) and Principle Component Regression Model (PCR). The proposed approaches were validated according to ICH guidelines and were applied for the determination of the ternary mixtures in their analytical mixtures and pharmaceutical preparation.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45702170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of HPLC Method for Simultaneous Estimation of Reduced and Oxidized Glutathione in Bulk Pharmaceutical Formulation 高效液相色谱法同时测定原料药中还原型和氧化型谷胱甘肽的开发与验证
Pub Date : 2021-03-03 DOI: 10.26420/AUSTININTERNMED.2021.1129
N. Singh, Akhtar Mj, A. Anchliya
The objective of this study was the development, optimization, and validation of a RP-HPLC method for the quantification of reduced glutathione (GSH) and oxidized glutathione (GSSG) in pharmaceutical formulations The separation utilized a C18 column at room temperature with absorption wavelength 210nm. The mobile phase was an isocratic flow of a 95:5 (v/v) mixture of 25mM phosphate buffer (pH 2.7) and methanol with flow rate at 1.0 mL/min. Validation of the method assessed with the methods ability in seven categories: linearity, range, limit of detection, limit of quantification, accuracy, precision, and selectivity. The method show an acceptable degree of linearity with r²=0.9994 and 0.999 over a concentration range of 10-200 μg/mL for GSH and GSSG respectively. The detection limit and quantification limit for GSH 20.7μg/mL and 69.24μg/mL and for GSSG 17.22μg/mL and 57.42μg/mL respectively. The percent recovery of the method was 99.98-100.93 %. Following validation, the method was employed in the determination of glutathione in pharmaceutical formulations in the form of a liposome. The proposed method offers a simple, accurate, and inexpensive way to quantify reduced glutathione.
本研究的目的是开发、优化和验证RP-HPLC方法,用于定量药物制剂中的还原型谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)。分离采用C18柱,室温下,吸收波长210nm。流动相为25mM磷酸盐缓冲液(pH 2.7)和甲醇的95∶5(v/v)混合物的等度流,流速为1.0mL/min。通过七类方法能力评估方法的有效性:线性、范围、检测限、定量限、准确度、精密度和选择性。该方法在10-200μg/mL的GSH和GSSG浓度范围内显示出可接受的线性度,r²分别为0.9994和0.999。GSH的检测限和定量限分别为20.7μg/mL和69.24μg/mL,GSSG分别为17.22μg/mL、57.42μg/mL。方法的回收率为99.98~100.93%。验证后,该方法被用于脂质体形式的药物制剂中谷胱甘肽的测定。所提出的方法提供了一种简单、准确和廉价的方法来量化还原型谷胱甘肽。
{"title":"Development and Validation of HPLC Method for Simultaneous Estimation of Reduced and Oxidized Glutathione in Bulk Pharmaceutical Formulation","authors":"N. Singh, Akhtar Mj, A. Anchliya","doi":"10.26420/AUSTININTERNMED.2021.1129","DOIUrl":"https://doi.org/10.26420/AUSTININTERNMED.2021.1129","url":null,"abstract":"The objective of this study was the development, optimization, and validation of a RP-HPLC method for the quantification of reduced glutathione (GSH) and oxidized glutathione (GSSG) in pharmaceutical formulations The separation utilized a C18 column at room temperature with absorption wavelength 210nm. The mobile phase was an isocratic flow of a 95:5 (v/v) mixture of 25mM phosphate buffer (pH 2.7) and methanol with flow rate at 1.0 mL/min. Validation of the method assessed with the methods ability in seven categories: linearity, range, limit of detection, limit of quantification, accuracy, precision, and selectivity. The method show an acceptable degree of linearity with r²=0.9994 and 0.999 over a concentration range of 10-200 μg/mL for GSH and GSSG respectively. The detection limit and quantification limit for GSH 20.7μg/mL and 69.24μg/mL and for GSSG 17.22μg/mL and 57.42μg/mL respectively. The percent recovery of the method was 99.98-100.93 %. Following validation, the method was employed in the determination of glutathione in pharmaceutical formulations in the form of a liposome. The proposed method offers a simple, accurate, and inexpensive way to quantify reduced glutathione.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47797398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Combination of FTIR Spectroscopy and Chemometric Method on Quantitative Approach - A Review FTIR光谱法与化学计量法在定量分析中的结合研究进展
Pub Date : 2021-03-03 DOI: 10.26420/AUSTININTERNMED.2021.1128
K. Verma, Akhtar Mj, A. Anchliya
Fourier transform infrared spectroscopy is an effectual and noncritical approach for quantitative study of different types analytes present in pharmaceutical and foodstuffs. The present review describes the basic principles and the instrumentation of FTIR spectroscopy along with its sample preparation techniques, sample handling techniques and advancements. FTIR spectroscopy in combination with chemometrics techniques has been followed over long times. The main objective of this review is to assemble the data linked to application of FTIR spectroscopic and chemometrics techniques for the quantitative study of varieties of analytes like API, adulterants, caffeine, cocaine, lipids, fats & oils, sugar and others. The FTIR spectroscopy with chemometrics techniques proved to be a beneficial methodology for quantitative study to routine analysis of these analytes.
傅立叶变换红外光谱法是定量研究药物和食品中不同类型分析物的一种有效且非关键的方法。本文综述了红外光谱的基本原理、仪器及其样品制备技术、样品处理技术和进展。FTIR光谱与化学计量技术相结合已经被跟踪了很长时间。本综述的主要目的是收集与FTIR光谱和化学计量技术应用相关的数据,用于各种分析物的定量研究,如API、掺杂物、咖啡因、可卡因、脂质、油脂、糖和其他。FTIR光谱和化学计量技术被证明是定量研究这些分析物的常规分析的有益方法。
{"title":"Combination of FTIR Spectroscopy and Chemometric Method on Quantitative Approach - A Review","authors":"K. Verma, Akhtar Mj, A. Anchliya","doi":"10.26420/AUSTININTERNMED.2021.1128","DOIUrl":"https://doi.org/10.26420/AUSTININTERNMED.2021.1128","url":null,"abstract":"Fourier transform infrared spectroscopy is an effectual and noncritical approach for quantitative study of different types analytes present in pharmaceutical and foodstuffs. The present review describes the basic principles and the instrumentation of FTIR spectroscopy along with its sample preparation techniques, sample handling techniques and advancements. FTIR spectroscopy in combination with chemometrics techniques has been followed over long times. The main objective of this review is to assemble the data linked to application of FTIR spectroscopic and chemometrics techniques for the quantitative study of varieties of analytes like API, adulterants, caffeine, cocaine, lipids, fats & oils, sugar and others. The FTIR spectroscopy with chemometrics techniques proved to be a beneficial methodology for quantitative study to routine analysis of these analytes.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49225497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Development: Enantioselective Extraction in Chiral Separation 手性分离中对映体选择性萃取的研究进展
Pub Date : 2021-03-03 DOI: 10.26420/AUSTININTERNMED.2021.1130
M. Hashemi, Hadjmohammadi Mr
This paper discusses the recent development of enantioselective extraction methods. There are several methods in this field. The principles of all of enantioselective extraction methods are presented a focus on twophase extractions, in these methods used a chiral compound that named chiral selector, this compound distinguishes between two chiral isomers in complexation process, then one isomer more captured by chiral selector, and separation processes happen. The chiral selector should dissolve in on phase. In these methods, typical performance data are reported major emphasis on distribution ratio and enantioselectivity value or selectivity factor. In this paper, we introduce types of enantioselective extraction method, and discuss about them with several examples.
本文讨论了近年来对映选择性提取方法的发展。这个领域有几种方法。介绍了所有对映选择性提取方法的原理,重点介绍了两相提取,在这些方法中使用了一种手性化合物,称为手性选择器,该化合物在络合过程中区分了两种手性异构体,然后一种异构体被手性选择器捕获,并发生分离过程。手性选择子应在相中溶解。在这些方法中,典型的性能数据主要集中在分布比和对映选择性值或选择性因子上。本文介绍了几种对映选择性提取方法,并结合实例进行了讨论。
{"title":"Recent Development: Enantioselective Extraction in Chiral Separation","authors":"M. Hashemi, Hadjmohammadi Mr","doi":"10.26420/AUSTININTERNMED.2021.1130","DOIUrl":"https://doi.org/10.26420/AUSTININTERNMED.2021.1130","url":null,"abstract":"This paper discusses the recent development of enantioselective extraction methods. There are several methods in this field. The principles of all of enantioselective extraction methods are presented a focus on twophase extractions, in these methods used a chiral compound that named chiral selector, this compound distinguishes between two chiral isomers in complexation process, then one isomer more captured by chiral selector, and separation processes happen. The chiral selector should dissolve in on phase. In these methods, typical performance data are reported major emphasis on distribution ratio and enantioselectivity value or selectivity factor. In this paper, we introduce types of enantioselective extraction method, and discuss about them with several examples.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42862078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Important of B-Complex Vitamins in Treatment Protocol in Diabetic Patients 复合维生素b在糖尿病患者治疗方案中的重要性
Pub Date : 2021-01-25 DOI: 10.26420/austinjanalpharmchem.2022.1139
Gaafar A, Ayyad R
This search includes the vitamin B-species which must be taken by diabetic patients. Where these vitamins keep the health of patient not merely but help the metabolism of glucose which is the blood sugar. The vitamin B-complex must be prescribed before the drugs which treat the diabetes (Insulin and oral hypoglycaemics). Because these vitamins keep the integrity of patient health and play the major role of metabolism of glucose.
这项研究包括糖尿病患者必须服用的维生素B。这些维生素不仅可以保持患者的健康,而且有助于葡萄糖(即血糖)的代谢。维生素B复合物必须在治疗糖尿病的药物(胰岛素和口服低血糖症)之前开具处方。因为这些维生素保持了患者健康的完整性,并在葡萄糖的代谢中发挥着重要作用。
{"title":"Important of B-Complex Vitamins in Treatment Protocol in Diabetic Patients","authors":"Gaafar A, Ayyad R","doi":"10.26420/austinjanalpharmchem.2022.1139","DOIUrl":"https://doi.org/10.26420/austinjanalpharmchem.2022.1139","url":null,"abstract":"This search includes the vitamin B-species which must be taken by diabetic patients. Where these vitamins keep the health of patient not merely but help the metabolism of glucose which is the blood sugar. The vitamin B-complex must be prescribed before the drugs which treat the diabetes (Insulin and oral hypoglycaemics). Because these vitamins keep the integrity of patient health and play the major role of metabolism of glucose.","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47238118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A chiral HPLC-MS/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma. 手性HPLC-MS/MS同时定量人血浆中华法林对映体及其主要羟基化代谢产物CYP2C9和CYP3A4。
W Ju, K Peng, S Yang, H Sun, M Sampson, M Z Wang

Warfarin is an oral anticoagulant that requires frequent therapeutic drug monitoring due to a narrow therapeutic window, considerable interindividual variability in drug response, and susceptibility to drug-drug and drug-diet interactions. Enantiomeric separation and quantification of warfarin enantiomers and clinically important major hydroxylation metabolites are essential for drug interaction studies and phenotypic characterization of CYP2C9 and CYP3A4, the major cytochrome P450 (CYP) enzymes involved in warfarin metabolism. Here, we describe the development and validation of a chiral high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)-based quantification of R-warfarin, S-warfarin, S-7-hydroxywarfarin (the major CYP2C9 metabolite) and (9R;10S)-10-hydroxywarfarin (the CYP3A4 metabolite) in human plasma. Simple protein precipitation-based extraction showed good recovery of analytes (82.9 - 96.9%). The developed method exhibited satisfactory intra-day and inter-day accuracy and precision. The lower limits of detection were 0.25 nM (or ~0.08 ng/mL) for the warfarin enantiomers and 0.1 nM (or ~0.04 ng/mL) for S-7-hydroxywarfarin and (9R;10S)-10-hydroxywarfarin using only 50 µL plasma during extraction. The validated method was successfully applied to analyze plasma samples obtained from a healthy human subject who enrolled in a clinical drug interaction study involving warfarin.

华法林是一种口服抗凝血剂,由于治疗窗口较窄,药物反应的个体间差异较大,以及对药物-药物和药物-饮食相互作用的敏感性,需要经常监测治疗药物。华法林对映体和临床重要的主要羟基化代谢物的分离和定量对于药物相互作用研究和参与华法林代谢的主要细胞色素P450 (CYP)酶CYP2C9和CYP3A4的表型表征至关重要。在这里,我们描述了基于手性高效液相色谱-串联质谱(HPLC-MS/MS)的r -华法林、s -华法林、s -7-羟基华法林(主要CYP2C9代谢物)和(9R;10S)-10-羟基华法林(CYP3A4代谢物)的定量测定方法的开发和验证。简单蛋白沉淀法提取回收率为82.9 ~ 96.9%。所开发的方法具有令人满意的日间和日间准确度和精密度。华法林对映体的检出下限为0.25 nM(或~0.08 ng/mL), s -7-羟基华法林和(9R;10S)-10-羟基华法林的检出下限为0.1 nM(或~0.04 ng/mL)。该方法已成功应用于分析一名健康受试者的血浆样本,该受试者参加了一项涉及华法林的临床药物相互作用研究。
{"title":"A chiral HPLC-MS/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma.","authors":"W Ju,&nbsp;K Peng,&nbsp;S Yang,&nbsp;H Sun,&nbsp;M Sampson,&nbsp;M Z Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Warfarin is an oral anticoagulant that requires frequent therapeutic drug monitoring due to a narrow therapeutic window, considerable interindividual variability in drug response, and susceptibility to drug-drug and drug-diet interactions. Enantiomeric separation and quantification of warfarin enantiomers and clinically important major hydroxylation metabolites are essential for drug interaction studies and phenotypic characterization of CYP2C9 and CYP3A4, the major cytochrome P450 (CYP) enzymes involved in warfarin metabolism. Here, we describe the development and validation of a chiral high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)-based quantification of <i>R</i>-warfarin, <i>S</i>-warfarin, <i>S</i>-7-hydroxywarfarin (the major CYP2C9 metabolite) and (9<i>R</i>;10<i>S</i>)-10-hydroxywarfarin (the CYP3A4 metabolite) in human plasma. Simple protein precipitation-based extraction showed good recovery of analytes (82.9 - 96.9%). The developed method exhibited satisfactory intra-day and inter-day accuracy and precision. The lower limits of detection were 0.25 nM (or ~0.08 ng/mL) for the warfarin enantiomers and 0.1 nM (or ~0.04 ng/mL) for <i>S</i>-7-hydroxywarfarin and (9<i>R</i>;10<i>S</i>)-10-hydroxywarfarin using only 50 µL plasma during extraction. The validated method was successfully applied to analyze plasma samples obtained from a healthy human subject who enrolled in a clinical drug interaction study involving warfarin.</p>","PeriodicalId":91055,"journal":{"name":"Austin journal of analytical and pharmaceutical chemistry","volume":"1 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494745/pdf/nihms693615.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33893181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Austin journal of analytical and pharmaceutical chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1